Elucidating versatile roles of ErbB4 in ALS pathophysiology may provide us with ideas for the development of innovative disease‐modifying therapies for ALS such as modulation of ErbB4 functions by NRG or their analogs. The gene discussed is ERBB4; the disease is amyotrophic lateral sclerosis.